CUREMA

curema-logo

CuReMa is a consultancy firm that provides offer business-critical applications to SMB customers.

#Website #More

CUREMA

Social Links:

Industry:
Apps Consulting

Founded:
2007-08-19

Address:
Mechelen, Antwerpen, Belgium

Country:
Belgium

Website Url:
http://www.curema.be

Total Employee:
1+

Status:
Active

Contact:
32-473 51 40 32

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Nginx Google Apps For Business Google Google Cloud QUIC


Official Site Inspections

http://www.curema.be

  • Host name: 15.214.214.35.bc.googleusercontent.com
  • IP address: 35.214.214.15
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "CuReMa"

About Us - CureVac

With a single discovery, CureVac opened the world up to the potential of mRNA to treat diseases and create vaccines. Officially founded in 2000, CureVac is the world’s first company to successfully harness mRNA for medical …See details»

CureVac - Revolutionizing mRNA for life.

Jun 24, 2024 CureVac N.V. (Nasdaq: CVAC) – (May 6, 2022) Major shareholder dievini Hopp BioTech holding GmbH & Co. KG, DH-LT-Investments GmbH and Dietmar Hopp, along with …See details»

Novartis signs initial agreement with CureVac to manufacture …

Mar 4, 2021 Novartis to support global supply of another COVID-19 vaccine, leveraging manufacturing capacity and capabilities to help address pandemic.; Novartis plans to …See details»

Overview - CureVac

Nov 12, 2024 The Annual General Meeting (the “AGM”) of Shareholders of CureVac N.V. (the “Company”) was held on Thursday, June 24, 2021, at 2:00 p.m. Central European Summer Time.See details»

Curema Company Profile | Mechelen, Belgium - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Curema of Mechelen. Get the latest business insights from Dun & Bradstreet.See details»

CureVac COVID vaccine let-down spotlights mRNA design …

Jun 18, 2021 A trial volunteer in Belgium recieves a dose of CureVac's vaccine. Credit: Yves Herman/Reuters/Alamy. Two vaccines made using messenger RNA (mRNA) have proved …See details»

This New Covid Vaccine Could Bring Hope to the Unvaccinated …

May 5, 2021 CureVac’s product belongs to what many scientists refer to as the second wave of Covid-19 vaccines that could collectively ease the world’s demand. Novavax, a company …See details»

CureVac COVID-19 vaccine - Wikipedia

Endemic phase; Evacuations; Face masks; International aid; Origin; Lockdowns. by country; Misinformation. by governments; Fake treatments; Social distancing; SoftwareSee details»

CureVac Streamlines European Network for mRNA Product …

Sep 14, 2021 TÜBINGEN, Germany / BOSTON, USA – September 14, 2021. CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of …See details»

GSK and CureVac announce strategic mRNA technology …

Jul 20, 2020 For media and investors only. Issued: London UK; Tübingen, Germany/ Boston, MA, USA. Companies to collaborate on mRNA vaccine and monoclonal antibody research …See details»

THE COMPANY HISTORY OF CUREVAC

CureVa ompan istory PREAMBLE Dear readers, We’ve all experienced it – the sudden flashes of inspiration that turn into obsessions we can’t get rid of. That idea that consumes you, follows …See details»

CureVac launches 'RNA Printer' subsidiary to provide clients with ...

Mar 1, 2022 CureVac, a German biotech, formed a new subsidiary centered on th | CureVac, a German biotech, formed a new subsidiary centered on the company’s RNA Printer technology …See details»

CureVac N.V. (CVAC) Stock Price, Quote & News - Stock ... - Stock …

4 days ago Analyst Forecast. According to 3 analysts, the average rating for CVAC stock is "Hold." The 12-month stock price forecast is $10.0, which is an increase of 250.88% from the …See details»

EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)

Feb 12, 2021 EMA’s human medicines committee (CHMP) has started a rolling review of CVnCoV, a COVID?19 vaccine being developed by CureVac AG. The CHMP’s decision to …See details»

CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial

Jun 16, 2021 Both the World Health Organization and the Food and Drug Administration set a threshold of 50 percent efficacy to consider Covid-19 vaccines for emergency authorization. If …See details»

COVID-19 - CureVac

The virus spread to different parts of China and subsequently to numerous countries worldwide. On January 30, 2020, the World Health Organization (WHO) declared the outbreak under …See details»

Current view on novel vaccine technologies to combat human …

Dec 10, 2021 Introduction. Vaccination remains a very effective method of preventing infectious diseases and represents a relevant contribution to human health (Sallusto et al. 2010).The …See details»

List of organisations banned by the Government of India

Akhil Bharat Nepali Ekta Samaj (ABNES); Al-Badr; All Tripura Tiger Force (ATTF); Al-Qaeda / al-Qaeda in the Indian Subcontinent; Al-Umar-Mujahideen; Babbar Khalsa International; …See details»

CureVac Announces Positive Data in Older Adults from COVID-19 …

Jan 30, 2023 CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today …See details»